【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Glaucoma
06.1.1 Understanding the Disease
06.1.2 Types of Glaucoma
06.1.3 Etiology
06.1.4 Signs and Symptoms
06.1.5 Diagnosis
06.1.6 Management
06.1.7 Epidemiology
06.2 Dry Eye Syndrome
06.2.1 Understanding the Disease
06.2.2 Types of Dry Eye Syndrome
06.2.3 Causes of Dry Eye Syndrome
06.2.4 Risk Factors of Dry Eye Syndrome
06.2.5 Signs and Symptoms
06.2.6 Diagnosis
06.2.7 Management
06.3 Diabetic Retinopathy
06.3.1 Understanding the Disease
06.3.2 Etiology
06.3.3 Diagnosis
06.3.4 Classification
06.3.5 Epidemiology
06.3.6 Management
06.4 RVO
06.4.1 Understanding the Disease
06.4.2 Types of RVO
06.4.3 Etiology
06.4.4 Diagnosis
06.4.5 Management
06.5 AMD
06.5.1 Understanding the Disease
06.5.2 Stages of AMD
06.5.3 Types of AMD
06.5.4 Etiology
06.5.5 Signs and Symptoms
06.5.6 Diagnosis
06.5.7 Management
06.6 Macular Edema
06.6.1 Understanding the Disease
06.6.2 Etiology
06.6.3 Diagnosis
06.6.4 Management
06.7 Economic Burden of Ophthalmic Diseases
07.Pipeline Analysis
07.1 Pipeline Portfolio: Glaucoma
07.1.1 Rhopressa
07.1.2 Roclatan
07.1.3 Trabodenoson
07.1.4 Lomerizine HCl
07.1.5 Y-39983
07.2 Pipeline Portfolio: Dry Eye Syndrome
07.2.1 Lifitegrast
07.2.2 OPC-12759E
07.2.3 EBI-005
07.3 Pipeline Portfolio: Diabetic Retinopathy
07.3.1 Squalamine
07.3.2 K-115-R/Ripasudil Hydrochloride Hydrate
07.4 Pipeline Portfolio: AMD
07.4.1 Anecortave Acetate (Suspension)
07.4.2 E10030
07.4.3 Abicipar
07.5 Pipeline Portfolio: RVO
07.5.1 TLC399
07.5.2 AGN208397
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Disease Type
09.1 Global Ophthalmic Therapeutics Market by Disease Type
09.2 Glaucoma
09.3 Dry Eye Syndrome
09.4 Retinal Disorders
09.4.1 Diabetic Retinopathy
09.4.2 Macular Edema
09.4.3 AMD
09.4.4 RVO
09.5 Global Glaucoma Therapeutics Market
09.5.1 Market Size and Forecast
09.6 Global AMD Therapeutics Market
09.6.1 Market Size and Forecast
09.7 Global Macular Edema Therapeutics Market
09.7.1 Market Size and Forecast
09.8 Global Dry Eye Syndrome Therapeutics Market
09.8.1 Market Size and Forecast
09.9 Global Diabetic Retinopathy Therapeutics Market
09.9.1 Market Size and Forecast
09.10 Global RVO Therapeutics Market
09.10.1 Market Size and Forecast
10.Market Segmentation by Route of Administration
10.1 Topical
10.2 Systemic
10.2.1 IV
10.2.2 Oral
10.3 Intravitreal
11.Market Segmentation by Molecule Type
11.1 Biologics
11.2 Small Molecules
12.Market Segmentation by Dosage Form
12.1 Solutions
12.2 Implants
12.3 Pills
13.Geographical Segmentation
13.1 Global Ophthalmic Therapeutics Market by Geography 2014-2019
14.Buying Criteria
15.Market Growth Drivers
16.Drivers and Their Impact
17.Market Challenges
18.Impact of Drivers and Challenges
19.Market Trends
20.Trends and Their Impact
21.Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.2.1 Novartis
21.2.2 Actavis
21.2.3 F. Hoffmann-La Roche
21.2.4 Regeneron Pharmaceuticals
21.2.5 Bayer
21.2.6 Pfizer
21.2.7 Merck
21.3 Other and Future Prominent Vendors
22.Key Vendor Analysis
22.1 Actavis
22.1.1 Key Facts
22.1.2 Business Description
22.1.3 Business Segmentation
22.1.4 Business Segmentation by Revenue 2012 and 2013
22.1.5 Sales by Geography
22.1.6 Business Strategy
22.1.7 Key Information
22.1.8 SWOT Analysis
22.2 Bayer
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation by Revenue 2014
22.2.4 Business Segmentation by Revenue 2013 and 2014
22.2.5 Geographical Segmentation by Revenue 2014
22.2.6 Business Strategy
22.2.7 Recent Developments
22.2.8 SWOT Analysis
22.3 F. Hoffmann-La Roche
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation
22.3.4 Business Segmentation by Revenue 2012 and 2013
22.3.5 Sales by Geography
22.3.6 Business Strategy
22.3.7 Key Information
22.3.8 SWOT Analysis
22.4 Merck
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation by Revenue 2013
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Sales by Geography
22.4.6 Business Strategy
22.4.7 Key Developments
22.4.8 SWOT Analysis
22.5 Novartis
22.5.1 Key Facts
22.5.2 Business Description
22.5.3 Business Segmentation
22.5.4 Revenue by Business Segmentation
22.5.5 Revenue Comparison 2012 and 2013
22.5.6 Sales by Geography
22.5.7 Business Strategy
22.5.8 Key Developments
22.5.9 SWOT Analysis
22.6 Pfizer
22.6.1 Key Facts
22.6.2 Business Overview
22.6.3 Business Segmentation by Revenue 2014
22.6.4 Business Segmentation by Revenue 2013 and 2014
22.6.5 Geographical Segmentation by Revenue 2014
22.6.6 Business Strategy
22.6.7 Key developments
22.6.8 SWOT Analysis
22.7 Regeneron Pharmaceuticals
22.7.1 Key Facts
22.7.2 Business Overview
22.7.3 Product Segmentation
22.7.4 Revenue Product Segmentation
22.7.5 Business Strategy
22.7.6 Key Information
22.7.7 SWOT Analysis
23.Other Reports in This Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Major Ophthalmic Conditions
Exhibit 3: Types of Glaucoma
Exhibit 4: Development of Diabetic Retinopathy
Exhibit 5: Classification of Diabetic Retinopathy
Exhibit 6: Types of RVO
Exhibit 7: Types of AMD
Exhibit 8: Global Ophthalmic Therapeutics Market 2014-2019 ($ millions)
Exhibit 9: Global Ophthalmic Therapeutics Market by Disease Type
Exhibit 10: Global Ophthalmic Therapeutics Market by Disease Type 2014
Exhibit 11: Global Glaucoma Therapeutics Market 2014-2019 ($ millions)
Exhibit 12: Key Takeaways: Global Glaucoma Therapeutics Market
Exhibit 13: Global AMD Therapeutics Market 2014-2019 ($ millions)
Exhibit 14: Key Takeaways: Global AMD Therapeutics Market
Exhibit 15: Global Macular Edema Therapeutics Market 2014-2019 ($ millions)
Exhibit 16: Key Takeaways: Global Macular Edema Therapeutics Market
Exhibit 17: Global Dry Eye Syndrome Therapeutics Market 2014-2019 ($ millions)
Exhibit 18: Key Takeaways: Global Dry Eye Syndrome Therapeutics Market
Exhibit 19: Global Diabetic Retinopathy Therapeutics Market 2014-2019 ($ millions)
Exhibit 20: Key Takeaways: Global Diabetic Retinopathy Therapeutics Market
Exhibit 21: Global RVO Therapeutics Market 2014-2019 ($ millions)
Exhibit 22: Key Takeaways: Global RVO Therapeutics Market
Exhibit 23: Global Ophthalmic Therapeutics Market: YoY Growth Rate and Revenue by Disease Type 2014-2019
Exhibit 24: Global Ophthalmic Therapeutics Market by Route of Administration
Exhibit 25: Global Ophthalmic Therapeutics Market by Molecule Type
Exhibit 26: Global Ophthalmic Therapeutics Market by Dosage Form
Exhibit 27: Global Ophthalmic Therapeutics Market by Geography 2014
Exhibit 28: Major Drivers of Global Ophthalmic Therapeutics Market
Exhibit 29: Major Challenges in Global Ophthalmic Therapeutics Market
Exhibit 30: Major Trends in Global Ophthalmic Therapeutics Market
Exhibit 31: Vendor Ranking 2014
Exhibit 32: Novartis: YoY Revenue and Growth Rate of Lucentis 2011-2014 ($ millions)
Exhibit 33: Actavis: YoY Revenue of Restasis 2012-2014 ($ millions)
Exhibit 34: Actavis: YoY Revenue of Lumigan 2012-2014 ($ millions)
Exhibit 35: Actavis: YoY Revenue of Alphagan, Alphagan P, and Combigan 2012-2014 ($ millions)
Exhibit 36: F. Hoffmann-La Roche: YoY Revenue and Growth Rate of Lucentis 2011-2014 ($ millions)
Exhibit 37: Regeneron Pharmaceuticals: YoY Revenue and Growth Rate of Eylea 2011-2014 ($ millions)
Exhibit 38: Bayer: YoY Revenue and Growth Rate of Eylea 2012-2014 ($ millions)
Exhibit 39: Pfizer: YoY Revenue and Growth Rate of Xalatan/Xalacom 2012-2014 ($ millions)
Exhibit 40: Actavis: Business Segmentation 2013
Exhibit 41: Actavis: Business Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 42: Actavis: Sales by Geography ($ millions)
Exhibit 43: Bayer: Business Segmentation by Revenue 2014
Exhibit 44: Bayer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 45: Bayer: Geographical Segmentation by Revenue 2014
Exhibit 46: Business Segmentation of F. Hoffmann-La Roche 2013
Exhibit 47: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 48: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 49: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
Exhibit 50: Merck: Business Segmentation by Revenue 2013
Exhibit 51: Merck: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 52: Merck: Sales by Geography 2013
Exhibit 53: Novartis: Business Segmentation
Exhibit 54: Novartis: Revenue by Business Segmentation 2013
Exhibit 55: Novartis AG: Revenue by Business Segmentation 2012 and 2013 ($ millions)
Exhibit 56: Novartis: Revenue by Geographical Segmentation 2013
Exhibit 57: Pfizer: Business Segmentation by Revenue 2014
Exhibit 58: Pfizer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 59: Pfizer: Geographical Segmentation by Revenue 2014
Exhibit 60: Regeneron Pharmaceuticals: Product Segmentation
Exhibit 61: Regeneron Pharmaceuticals: Revenue Product Segmentation 2013
【レポート販売概要】
■ タイトル：眼科疾患治療薬の世界市場：緑内障、眼球乾燥症候群、網膜障害（糖尿病性網膜症、黄斑浮腫、RVO、AMD）■ 英文：Global Opthalmic Therapeutic Market 2015-2019
■ 発行日：2015年7月22日
■ 調査会社：Technavio
■ 商品コード：IRTNTR6492
■ 調査対象地域：グローバル
- 世界の産業用イーサネット市場動向（2014-2018）TechNavio’s analysts forecast the Global Industrial Ethernet market will grow at a CAGR of 9.85 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to reduce capital and operational expenditure. The Global Industrial Ethernet market has also been witnessing the introduction of cost-effective Ethernet devices. However, the increase in points of f …
- 世界のメシチレン市場2015The Global Mesitylene Industry Report 2015 is a professional and in-depth study on the current state of the Mesitylene industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Mesitylene market analysis is provided for the international markets including development trends, competitive landscape analysis, …
- ペクチンの世界市場2017-2021About Pectin Pectin was first discovered in 1790 by the French chemist Louis Nicola Vauquelin. He was able to separate from fruit juice, a water-soluble substance that turns liquids into a gel. The name pectin is derived from the Greek word “pektos” that means curdling or congealing. The beneficial properties of pectin were discovered immediately even before its chemical composition was determined …
- 眼瞼炎治療薬の世界市場：ステロイド、抗生物質Global Blepharitis Drugs Market: About this market Blepharitis drugs include steroids and antibiotics, which are used to treat inflammation in the eyelids and infection. Technavio’s blepharitis drugs market analysis considers sales from the steroids and antibiotics segments. Our analysis also considers the sales of blepharitis drugs in Asia, Europe, North America, and ROW. In 2018, the steroids se …
- 産業用バルブ及びアクチュエータの世界市場：クォーターターンバルブ、マルチターンバルブ、アクチュエータ、コントロールバルブAbout Industrial Valves and Actuators The oil and gas industry is one of the major users of industrial valves and actuators. The rise in exploration and production of oil and gas in North America, MEA, and APAC will be the major contributor to the steady growth of the global industrial valves and actuators market. The market will be dominated by EMEA, followed by APAC and the Americas. APAC is exp …
- プリンテッドエレクトロニクスの世界市場2017-2021About Printed ElectronicsPrinted electronics is a set of printing methods, which is used to create electrical devices on different substrates such as plastic, ceramic, and textiles Technavio’s analysts forecast the global printed electronics market to grow at a CAGR of 8.26% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the …
- グローバルFMCG事業景況感サーベイ（2015年上半期）Summary “FMCG Business Confidence Report H1 2015” is a new report by Canadean that globally analyzes industry opinions on the latest economic and consumer issues, and their impact on investment decisions and growth prospects within the FMCG industry. This report also examines executive opinion about the current and future state of the economy and its retrospective effect on the industry. Furthermo …
- 世界のワイン市場：ニュース、イベント動向（2014年3月）Synopsis The report provides a review of the latest news and key events in the global wine market during March 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global wine market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global wine market …
- エチレン(ET)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world ethylene market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insight …
- 抗菌塗料の世界市場2015-2019About Antimicrobial Coatings Antimicrobial coatings assist in maintaining surface quality and prevent the formation of cracks, bubbles, rust, fungus, and algae. These coatings inhibit the growth of pathogens on surfaces. Antimicrobial coatings are used in various applications in the fields of architecture, infrastructure, automotive, healthcare, textiles, food and beverages, and consumer durables. …
- ブラジルの患者診察機器市場見通し（～2021）Brazil Patient Examination Devices Market Outlook to 2021 Summary GlobalData’s new report, "Brazil Patient Examination Devices Market Outlook to 2021", provides key market data on the Brazil Patient Examination Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Stethoscopes and Thermometers. The r …
- 永久磁石モーターの世界市場：NdFeBモーター、SmCoモーター、フェライトモーターAbout Permanent Magnet Motor A permanent magnet is made from ferromagnetic materials, and it creates its own magnetic field and retains magnetic properties. Permanent magnet exhibits magnetic properties even if is removed from a magnetic field. Permanent magnet can be broadly classified into rare earth, ferrite, aluminum-nickel-cobalt (Alnico), and other magnets. Permanent magnet motor is manufact …
- 建設重機の世界市場2015-2022According to Stratistics MRC, the Global Heavy Construction Equipment Market is valued at $116.48 billion in 2015 and is expected to grow at a CAGR of 7.34% to reach $191.34 billion by 2022. Growth in construction activity is one of the major factors fueling the market growth. Reduction in the cost of labor and time are favoring the market to grow. Economic development and rise in infrastructural …
- 世界のアプリケーションプラットフォーム市場：展開別、地域別Global Application Platform Market: About this market Technavio’s application platform market analysis considers sales from both on-premises and aPaaS deployment. Our study also finds the sales of application platform in APAC, Europe, MEA, North America, and South America. In 2019, the on-premises segment had a significant market share, and this trend is expected to continue over the forecast peri …
- クラスタリングソフトウェアの世界市場2015-2019About Clustering Software A cluster is a set of computers connected to form a single server resource for many web applications. Clustering is a method of transforming multiple computer servers into one group. The software is installed in each server that is connected to the network. The architecture of clustering software improves the performance and scalability of servers, and reduces operating c …
